Dr. Jean-Yves Dastain graduated in Paris, France from the University Pierre et Marie Curie (Paris VI), Medical School: Broussais Hotel Dieu, Paris and received his Medical Diploma in 1983.
Dr. Jean-Yves Dastain had a career in an Academic Hospital in Paris as Chief Attending Physician until retired at 62 year old.
Dr. Jean-Yves Dastain spent 9 months at Memorial Sloan Kettering Cancer Center in Manhattan in the Cardiology Unit. He attended New York Medical School in 2012 and after passing all the required USMLE exams, got a New York and later a Florida Medical License. The US residency was waived after his background was vetted by the Boards.
Dr. Jean-Yves Dastain was working in Urgent Care Center in Manhattan and the Bronx with his private practice in Manhattan near South Central Park, mainly Aesthetic Medicine after receiving a Diploma from Aesthetic Medical Training in New York and La Clinique des Champs Elysees in Paris, France for special training in Laser Technique.
After 7 years of practice in Manhattan Dr Dastain relocated to Naples, Florida, with his family and started practicing Laser Treatment for Skin Blemishes and Aesthetic Medicine with Botox & Filler Injection in his new location in Florida.
Dr Dastain is fluent in English, French, German and Italian and is a member of the American Medical Association.
Actinic and seborrheic keratosis, warts, moles, skin tags, epidermal and dermal nevi, xanthelasma.
Other conditions that have been shown to respond favorably to CO2 laser resurfacing include dermatofibroma, severe cutaneous photodamage (observed in Favre-Racouchot syndrome), sebaceous hyperplasia, syringomas, actinic cheilitis, scar treatment, keloid, skin cancer, neurofibroma, diffuse actinic keratoses, granuloma pyogenicum, pearly penile papules, condyloma acuminata.
Periorbital and perioral wrinkles, facial resurfacing and acne scars, dyschromias including solar lentigines.
Click here to go to specific documentation about CO2 laser technique:
Isotretinoin use within the previous six months, active cutaneous bacterial or viral infection in the area to be treated, history of keloid formation or hypertrophic scarring, ongoing ultraviolet exposure, prior radiation therapy to treatment area, collagen vascular disease, chemical peel and dermabrasion.